Connect with Us at the Upcoming Events

With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!

Book a Meeting

γδ T Cell Service

γδ T Cell Activation and Expansion Services

γδ T Cell Activation and Expansion Services

Online Inquiry

γδ T cells are promising candidates for developing anti-cancer immunotherapy. However, the lack of suitable expansion methods has hindered the wide application of γδ T cells in cellular immunotherapy. Creative Biolabs has organized a staff of excellent experts who have focused on the research of γδ T cell for many years. We provide optimal solutions for γδ T cell activation and expansion to support the development of γδ T cell-based immunotherapies.

Brief Introduction to γδ T Cell Activation and Expansion

γδ T cells have been regarded as promising candidates for developing γδ T cell based anti-tumor immunotherapy due to their unique anti-tumor activities. During the development of γδ T cell based immunotherapy, it is very important to achieve enough numbers of γδ T cell. In general, there have two strategies for γδ T cell expansion: ex vivo and in vivo. The first method is to expand γδ T cells isolated from peripheral blood mononuclear cells (PBMCs) ex vivo using synthetic phosphoantigen (pAg) or bisphosphonates (BP) such as zoledronic acid. These ex vivo expanded γδ T cells have been applied in clinical trials and shown promising anti-tumor effects. The second method is to stimulate and expand γδ T cells in vivo by systemic administration of pAg or nitrogenous-BP (N-BP).

Services

Creative Biolabs is a world-leading service provider who is devoted to offering the best γδ T cell development services for global clients, including γδ T cell isolation, activation and expansion, characterization, production, cytotoxicity test, and migration assay. Especially, our scientists are very skilled in the research of γδ T cell activation and expansion and can offer a great diversity of in vitro or in vivo solutions, including a customized solution for γδ T cell activation and expansion.

γδ T Cell Activation and Expansion Services

Vγ9Vδ2 T cells are the most abundant subset of circulating γδ T cells that has several features such as MHC-independent recognition of tumor cells and potent anti-tumor potential. Several studies have reported Vγ9Vδ2 cells can be activated and expanded in vitro and in vivo, thus make it possible to developing Vγ9Vδ2 cell-based immunotherapy. We offer top-quality services for activation and expansion of Vγ9Vδ2 T cells, accelerating the development of Vγ9Vδ2 cell-based immunotherapy.

γδ T Cell Activation and Expansion Services

Non-Vγ9Vδ2 T cells have been also revealed to exert a potent anti-tumor effect. Vδ1 γδ T cells (1-3% of lymphocytes) expanded from peripheral blood exhibited potent anti-tumor activity against multiple types of cancer, such as chronic lymphoid leukemia, multiple myeloma, breast cancer, and colorectal cancer. These non-Vγ9Vδ2 T cells have also attracted considerable attention for developing cancer immunotherapeutic approaches. We also offer multiple strategies for activation and expansion of non-Vγ9Vδ2 T cells (such as Vδ1 γδ T cells) to advance the development of non-Vγ9Vδ2 cell-based immunotherapy.

If you are interested in our γδ T cell activation and expansion services, please contact us for more details.

All listed services and products are for research use only. Do not use in any diagnostic or therapeutic applications.

Online Inquiry